Streptococcus equi but not Streptococcus zooepidemicus produces potent mitogenic responses from equine peripheral blood mononuclear cells

Veterinary Immunology and Immunopathology

Volumn 67, Issue 3, 1999, Pages 235-246

  Anzai, T ^b   Sheoran, A S ^a   Kuwamoto, Y ^b   Kondo, T ^b   Wada, R ^b   Inoue, T ^c   Timoney, J F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b EQUINE RESEARCH INSTITUTE   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Culture supernatant; Mitogen; Mitogenic response; Mitogenicity; Strangles; Streptococcus equi; Streptococcus zooepidemicus

Indexed keywords

CONCANAVALIN A; FIBRINOGEN; MITOGENIC AGENT; PROTEINASE K;

ARTICLE; BACTERIUM ISOLATE; FIBRINOGEN BLOOD LEVEL; HORSE; HORSE DISEASE; MEDIATOR RELEASE; MITOGENESIS; MITOGENICITY; MONONUCLEAR CELL; NEUTROPHILIA; NONHUMAN; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUI ZOOEPIDEMICUS;

ANIMALS; CELLS, CULTURED; ENDOPEPTIDASE K; HEAT; HORSE DISEASES; HORSES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MITOGENS; RABBITS; STREPTOCOCCUS EQUI;

BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; STREPTOCOCCUS; STREPTOCOCCUS EQUI SUBSP. ZOOEPIDEMICUS;

EID: 0033593827     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00227-X     Document Type: Article

References (34)

1. Anzai T., Nakanishi A., Wada R., Higuchi T., Hagiwara S., Takazawa M., Oobayashi K., Inoue T. Isolation of Streptococcus equi subsp. equi from thoroughbred horses in a racehorse-breeding area of Japan. J. Vet. Med. Sci. 59:1997;1031-1033.
2. Assimacopoulos, A.P., Stoehr, J.A., Schlievert, P.M., 1997. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome, In: Horaud, T., Bouvet, A., Leclercq, R., de Montclos, H., Sicard, M. (Eds.), Advances in Experimental Medicine and Biology, vol. 418, Plenum Press, New York, pp. 109-114.
3. Bazely P.L. Studies with equine streptococci. IV. Cross immunity to Streptococcus equi. Aust. Vet. J. 18:1942;189-197.
4. Boschwitz J.F., Timoney J.F. Inhibition of C3 deposition on Streptococcus equi subsp. equi by SeM: A mechanism of survival in equine blood. Infect. Immun. 62:1994;3515-3520.
5. Chanter, N., Collin, N.C., Mumford, J.A., 1994. Resistance of Streptococcus equi in vitro to equine polymorphnuclear leucocytes, In: Plowright, W., Nakajima, H. (Eds.) Proc. Seventh Int. Conf. on Equine Infectious Diseases. R and W Publications, Newmarket, UK, pp. 201-205.
6. de Azavedo J.C., Drumm A., Jupin C., Parant M., Alouf J.E., Arbuthnott J.P. Induction of tumour necrosis factor by staphylococcal toxic shock syndrome toxin 1. FEMS Microbiol. Immunol. 1:1988;69-74.
7. Easmon, C.S.F., Goodfellow, M., 1990. Staphylococcus and micrococcus, In: Parker, M.T., Duerden, B.I. (Eds.), Topley and Wilson's Principles of Bacteriology, Virology and Immunity, B.C. Decker, Philadelphia, PA, pp. 162-1186.
8. Farrow J.A.E., Collins M.D. Taxonomic studies on streptococci of serological groups C, G and L and possibly related taxa. System. Appl. Microbiol. 5:1984;483-493.
9. Fast D.J., Schlievert P.M., Nelson R.D. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect. Immun. 57:1989;291-294.
10. Galan J.E., Timoney J.F. Immunologic and genetic comparison of Streptococcus equi isolated from the United States and Europe. J. Clin. Microbiol. 26:1988;1142-1146.
11. Hackett S.P., Stevens D.L. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome and potent inducers of tumor necrosis fctor-β synthesis. J. Infect. Dis. 168:1993;232-235.
12. Jorm L.R., Love D.N., Bailey G.D. Genetic structure of populations of β-haemolytic Lancefield group C streptococci from horses and their association with disease. Res. Vet. Sci. 57:1994;292-299.
13. Jupin C., Anderson S., Damais C., Aloug J.E., Parant M. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J. Exp. Med. 167:1988;752-761.
14. Kasai K., Nobata R., Raya E. On the incidence of Streptococcus hemolyticus in the normal tonsil of horses and of the typing of equine tonsillar streptococci. Jpn. J. Vet. Sci. 6:1994;116-123.
15. Kline J.B., Collins C.M. Analysis of the superantigenic activity of mutant and allelic forms of streptococal pyrogenic exotoxin A. Infect. Immun. 64:1996;861-869.
16. Kondo T., Sugiura T., Kamada M., Imagawa H. Colorimetric assay of equine peripheral lymphocyte blastogenesis using MTT. J. Equine Sci. 7:1996;63-66.
17. Kotb M. Role of superantigens in the pathogenesis of infectious diseases and their sequelae. Curr. Opin. Infect. Dis. 5:1992;364-374.
18. Micusan V.V., Mercier G., Bhatti A.R., Reiser R.F., Bergdoll M.S., Oth D. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1. Immunology. 58:1986;203-208.
19. Micusan V.V., Desrosiers M., Gosselin J., Mercier G., Oth D., Bhatti A.R., Heremans H., Billiau A. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin-1. Rev. Infect. Dis. 11(Suppl):1989;305-312.
20. Mollick J.A., Miller G.G., Musser J.M., Cook R.G., Grossman D., Rich R.R. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92:1993;710-719.
21. Moore, B.T., Bryans, J.T., 1970. Type specific antigenicity of group C streptococci from diseases of the horse, In: Bryans, J.T., Gerber, H. (Eds.), Proc. Second Int. Conf. on Equine Infectious Diseases, Karger, Paris/Basel, pp. 231-238.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
23. Norrby-Teglund A., Newton D., Kotb M., Holm S.E., Norgen M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect. Immun. 62:1994;5227-5233.
24. Rago J.V., Schlievert P.M. Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens. Curr. Top. Microbiol. Immunol. 225:1997;81-97.
25. Schlievert P.M. Role of superantigens in human disease. J. Infect. Dis. 167:1993;997-1002.
26. Schlievert P.M., Bettin K.M., Watson D.W. Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infect. Immun. 16:1997;673-679.
27. Schmidt K., Gerlach D., Wollweber L., Reichardt W., Mann K., Ozegowski J., Fleischer B. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF. Infect. Immun. 63:1995;4569-4575.
28. Schuh V., Hribalova V., Atkins E. The pyrogenic effect of scarlet fever toxin. IV. Pyrogenicity of strain C203 U filtrate: Comparison with some basic characteristics of the known type of scarlet fever toxin. Yale J. Biol. Med. 43:1970;31-42.
29. Timoney J.F., Walker J., Zhou M., Ding J. Cloning and sequence analysis of a protective M-like protein gene from Streptococcus equi subsp. zooepidemicus. Infect. Immun. 63:1995;1440-1445.
30. Timoney J.F., Artiushin S.C., Boschwitz J.F. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infect. Immun. 65:1997;3600-3605.
31. Tomai M.A., Aelion J.A., Dockter M.E., Majumdar G., Spinellea D.G., Kotb M. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M Protein. J. Exp. Med. 174:1991;285-288.
32. Ulrich R.G., Olson M.A., Bavori S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine. 16:1998;1857-1864.
33. Watanabe-Ohnishi R., Aelion J., LeCros L., Tomai M.A., Sokurenko V.E., Newton D., Takahara J., Irino S., Rashed S., Kotb M. Characterization of unique human TCR Vβ specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J. Immun. 152:1994;2066-2073.
34. Walker J.A., Timoney J.F. Molecular basis of variation in protective SeP proteins of Streptococcus zooepidemicus. Am. J. Vet. Res. 59:1988;1129-1133.